Engelsk

The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulär  
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
pht000371
Beskrivning

pht000371

HAS GENETIC SPECIMEN (ALL PARTICIPANTS)
Beskrivning

HASGENSP

Datatyp

text

Alias
UMLS CUI [1,1]
C0017399
UMLS CUI [1,2]
C0370003
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL AMD PHENOTYPE (ALL PARTICIPANTS)
Beskrivning

AMDSTAT

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0242383
UMLS CUI [1,3]
C0031437
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL CATARACT PHENOTYPE (ALL PARTICIPANTS)
Beskrivning

CATARACT

Datatyp

text

Alias
UMLS CUI [1,1]
C0086543
UMLS CUI [1,2]
C0031437
UMLS CUI [1,3]
C3853528
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
Beskrivning

COR

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0027361
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
DUMMY ID NUMBER
Beskrivning

ID2

Datatyp

string

Alias
UMLS CUI [1,1]
C2348585
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LPSCBASE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C4228349
UMLS CUI [1,3]
C0439165
UMLS CUI [1,4]
C0205099
UMLS CUI [1,5]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LCOR

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LCORBASE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0439165
UMLS CUI [1,4]
C0205379
UMLS CUI [1,5]
C0023317
UMLS CUI [1,6]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LCORSCORE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C2938874
UMLS CUI [1,4]
C0439165
UMLS CUI [1,5]
C0229090
UMLS CUI [1,6]
C0205379
UMLS CUI [1,7]
C0023317
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LNUC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938873
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (ALL PARTICIPANTS)
Beskrivning

LNUCBASE

Datatyp

float

Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C2938873
UMLS CUI [1,3]
C0449820
UMLS CUI [1,4]
C0681889
UMLS CUI [1,5]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LNUCSCORE

Datatyp

float

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C2938873
UMLS CUI [1,4]
C0449820
UMLS CUI [1,5]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LPSC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C4228349
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
Beskrivning

LPSCSCORE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C4228349
UMLS CUI [1,4]
C0439165
UMLS CUI [1,5]
C0205099
UMLS CUI [1,6]
C0229090
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
Beskrivning

NUC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938873
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0027361
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PSC OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
Beskrivning

PSC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C4228349
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0027361
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RPSCBASE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C4228349
UMLS CUI [1,3]
C0439165
UMLS CUI [1,4]
C0205099
UMLS CUI [1,5]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RCOR

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RCORBASE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C2938874
UMLS CUI [1,3]
C0439165
UMLS CUI [1,4]
C0205379
UMLS CUI [1,5]
C0023317
UMLS CUI [1,6]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RCORSCORE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C2938874
UMLS CUI [1,4]
C0439165
UMLS CUI [1,5]
C0205379
UMLS CUI [1,6]
C0023317
UMLS CUI [1,7]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RNUC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C2938873
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (ALL PARTICIPANTS)
Beskrivning

RNUCBASE

Datatyp

float

Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C2938873
UMLS CUI [1,3]
C0449820
UMLS CUI [1,4]
C0681889
UMLS CUI [1,5]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RNUCSCORE

Datatyp

float

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C2938873
UMLS CUI [1,4]
C0449820
UMLS CUI [1,5]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RPSC

Datatyp

text

Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C4228349
UMLS CUI [1,3]
C0031437
UMLS CUI [1,4]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (ALL PARTICIPANTS)
Beskrivning

RPSCSCORE

Datatyp

float

Måttenheter
  • percent
Alias
UMLS CUI [1,1]
C3853528
UMLS CUI [1,2]
C0681842
UMLS CUI [1,3]
C4228349
UMLS CUI [1,4]
C0439165
UMLS CUI [1,5]
C0205099
UMLS CUI [1,6]
C0229089
UMLS CUI [2,1]
C0681850
UMLS CUI [2,2]
C0444868
percent
Tillbaka till toppen

Similar models

The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.

19 Formulär
  1. StudyEvent: NEI Age-Related Eye Disease Study (AREDS)
    1. Eligibility Criteria
    2. The data table (n=142 variables) contains AMD and cataract phenotype information, medical history and socio-demographic information drawn from several data sets (e.g. enrollment_randomization, amdlensphenotype, followup), plus a unique patient identifier (ID2) for participants with a genetic specimen (to be found only in GENSPECPHENOTYPE and GENSPECFUNDUSLENS [pht000376] tables). Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Other disease information (e.g. diabetes, cancer, angina), medical information (e.g. BMI, blood pressure) and smoking status are also included annually throughout follow-up.
    3. The data table (n=12 variables) contains information about the occurrence of adverse events during the AREDS clinical trial, e.g. type of adverse event, severity, primary ICD9 code, outcome, potential relationship to study drug, timing, and treatment. Data were collected through the clinical trial and for the first 6 months of the natural history follow-up immediately after the clinical trial concluded. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    4. The data table (n=25 variables) contains detailed information about cataract phenotypes (n=23 variables) as well as final AMD phenotype (n=1 variable), and patient ID. Nuclear, cortical and posterior subcapsular opacity information is included for both eyes at baseline and end of study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    5. The data table (n=56 variables) contains information about AREDS participants' dietary intake of alcohol, amino acids, carbohydrates, fiber, poly- and monounsaturated fatty acids, proteins, vitamins and minerals. Participants' glycemic index and glycemic load are also included. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    6. The data table (n=102 variables) contains AREDS treatment assignment, basic socio-demographic characteristics and baseline medical history for AREDS participants. Medical history information includes eye disease information such as AMD Category, visual acuity, and past ophthalmic treatments (e.g. cataract surgery, laser treatment), as well as information about the presence/absence of other diseases (e.g. angina, arthritis, cancer, diabetes, high blood pressure), use of prescribed drugs for disease management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), intake of vitamins and minerals, and smoking history. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    7. The data table (n=83 variables) contains information obtained at follow-up visits during the AREDS clinical trial (every six months following randomization), annually in person during the natural history follow-up, and via phone between annual in-person visits. Variables include information about AREDS participants' ophthalmic medical history (e.g. cataract or other eye surgery, laser treatment for AMD, retinal repair, capsulotomy, presence/absence of lens, glaucoma, and visual acuity) and general medical information, including new diagnoses of cancer, heart disease, stroke, and peripheral vascular disease, disease history of angina and high blood pressure, current disease status of diabetes, arthritis, and gout, use of prescribed drugs for disease treatment or management (e.g. blood-thinning medications, digoxin, thyroid hormones, insulin), use of over-the-counter drugs (e.g. NSAIDs, antacids), and smoking behavior. For version 3 release of the study, visual acuity data of the right eye have been added for odd-numbered visits. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    8. The data table (n=49 variables) contains information from AREDS participants' fundus photographs, including presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy. In addition, information on photocoagulation (PC) treatment for AMD SRNV is included, as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    9. The data table (n=62) contains information only for AREDS participants who have a genetic specimen. A unique patient identifier (ID2 field) for these participants (to be found only in GENSPECPHENOTYPE [pht000001.v2.p1] and GENSPECFUNDUSLENS data tables) is included instead of the patient identifier used for data tables with all participants (ID field). Information about fundus and lens characteristics are included as follows - fundus: presence, type, and extent of drusen, presence/extent of RPE depigmentation, SSR (serous sensory retinal) detachments, subretinal hemorrhages, subretinal fibrosis, and geographic atrophy; lens: degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. In addition, information on photocoagulation (PC) treatment for AMD is included as well as AMD Severity Scale Scores and AMD Simple Scale Scores calculated from the fundus data.
    10. The data table (n=6 variables) contains information about AREDS participant hospitalizations (e.g. reason, time from randomization, duration, primary ICD9 code) during the entire study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    11. The data table (n=21 variables) contains information from AREDS participants' lens photographs, including degree of nuclear sclerosis, cortical and posterior subcapsular opacities, and iris pigmentation. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    12. The data table (n=7 variables) contains information about AREDS participant deaths (e.g. cause, time from randomization) during the entire study. A search using the National Death Index (NDI) yielded additional deaths not identified during the study. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    13. The data table (n=44 variables) contains information about AREDS participants' use (e.g. type, frequency, dose, duration) of non-steroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, acetaminophen, naproxen). Data were collected at in-clinic visits starting in October 2004. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    14. The data table (n=16 variables) contains information about AREDS participants' general vision status (e.g. general vision score, ocular pain score, VFQ overall score), and its effect on participants' behavior (e.g. near and distant activities, social activities, driving, mental health score) as obtained through the VFQ-25 questionnaire. Note: In version 3, the ID has been replaced by ID2 identifier for all subjects.
    15. Subject - Consent Information
    16. Subject - Sample Mapping (including mapping to Coriell IDs)
    17. The data table (n=2 variables) contains information on subjects' annual exposure to sunlight (hours; April through September).
    18. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
    19. This dataset provides refractive error values obtained from control subjects of the AREDS study (phs000001.v3.p1) and represents a substudy of AREDS ; data of n=7 new variables are provided in addition to basic sociodemographic data. Subject - consent and subject - sample mapping information is available through phs000001.v3.p1.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht000371
Item
HAS GENETIC SPECIMEN (ALL PARTICIPANTS)
text
C0017399 (UMLS CUI [1,1])
C0370003 (UMLS CUI [1,2])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
HASGENSP
Code List
HAS GENETIC SPECIMEN (ALL PARTICIPANTS)
CL Item
No (N)
C1298908 (UMLS CUI [1,1])
CL Item
Yes (Y)
C1705108 (UMLS CUI [1,1])
Item
FINAL AMD PHENOTYPE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C0242383 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
AMDSTAT
Code List
FINAL AMD PHENOTYPE (ALL PARTICIPANTS)
CL Item
Control (1)
C0009932 (UMLS CUI [1,1])
CL Item
Control Questionable 1 (2)
C0009932 (UMLS CUI [1,1])
C0332241 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
CL Item
Control Questionable 2 (3)
C0009932 (UMLS CUI [1,1])
C0332241 (UMLS CUI [1,2])
C0205436 (UMLS CUI [1,3])
CL Item
Control Questionable 3 (4)
C0009932 (UMLS CUI [1,1])
C0332241 (UMLS CUI [1,2])
C0205437 (UMLS CUI [1,3])
CL Item
Control Questionable 4 (5)
C0009932 (UMLS CUI [1,1])
C0332241 (UMLS CUI [1,2])
C0205438 (UMLS CUI [1,3])
CL Item
Large Drusen (6)
C0549177 (UMLS CUI [1,1])
C1260959 (UMLS CUI [1,2])
CL Item
Large Drusen Questionable 1 (7)
C0549177 (UMLS CUI [1,1])
C1260959 (UMLS CUI [1,2])
C0332241 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
CL Item
Large Drusen Questionable 2 (8)
C0549177 (UMLS CUI [1,1])
C1260959 (UMLS CUI [1,2])
C0332241 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
CL Item
Large Drusen Questionable 3 (9)
C0549177 (UMLS CUI [1,1])
C1260959 (UMLS CUI [1,2])
C0332241 (UMLS CUI [1,3])
C0205437 (UMLS CUI [1,4])
CL Item
Questionable AMD (10)
C0332241 (UMLS CUI [1,1])
C0242383 (UMLS CUI [1,2])
CL Item
NV AMD (11)
C4068891 (UMLS CUI [1,1])
C0242383 (UMLS CUI [1,2])
CL Item
GA (12)
C1536085 (UMLS CUI [1,1])
CL Item
Both NV AMD and GA (13)
C0242383 (UMLS CUI [1,1])
C4068891 (UMLS CUI [1,2])
C1536085 (UMLS CUI [1,3])
CL Item
Other non-control (14)
C0205394 (UMLS CUI [1,1])
C1298908 (UMLS CUI [1,2])
C0009932 (UMLS CUI [1,3])
Item
FINAL CATARACT PHENOTYPE (ALL PARTICIPANTS)
text
C0086543 (UMLS CUI [1,1])
C0031437 (UMLS CUI [1,2])
C3853528 (UMLS CUI [1,3])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
CATARACT
Code List
FINAL CATARACT PHENOTYPE (ALL PARTICIPANTS)
CL Item
Absent (1)
C0332197 (UMLS CUI [1,1])
CL Item
Nuclear alone (2)
C0392557 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
CL Item
Cortical alone (3)
C0271160 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
CL Item
PSC alone (4)
C0858617 (UMLS CUI [1,1])
C0205171 (UMLS CUI [1,2])
CL Item
Nuclear/Cortical (5)
C0271160 (UMLS CUI [1,1])
C0392557 (UMLS CUI [1,2])
CL Item
Nuclear/PSC (6)
C0392557 (UMLS CUI [1,1])
C0858617 (UMLS CUI [1,2])
CL Item
Cortical/PSC (7)
C0271160 (UMLS CUI [1,1])
C0858617 (UMLS CUI [1,2])
CL Item
Nuclear/Cortical/PSC (8)
C0392557 (UMLS CUI [1,1])
C0271160 (UMLS CUI [1,2])
C0858617 (UMLS CUI [1,3])
CL Item
Cataract Surgery/No specific type (9)
C2939459 (UMLS CUI [1,1])
C1298908 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C0086543 (UMLS CUI [2,3])
CL Item
Questionable (10)
C0332241 (UMLS CUI [1,1])
Item
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0027361 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
COR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
CL Item
Absent (0)
C0332197 (UMLS CUI [1,1])
CL Item
Present (1)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (2)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (3)
C0332241 (UMLS CUI [1,1])
ID2
Item
DUMMY ID NUMBER
string
C2348585 (UMLS CUI [1,1])
LPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0205099 (UMLS CUI [1,4])
C0229090 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229090 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LCOR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
CL Item
Absent (COR-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (COR-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (COR-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (COR-D)
C0332241 (UMLS CUI [1,1])
LCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - LEFT EYE (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0205379 (UMLS CUI [1,4])
C0023317 (UMLS CUI [1,5])
C0229090 (UMLS CUI [1,6])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - LEFT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C2938874 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0229090 (UMLS CUI [1,5])
C0205379 (UMLS CUI [1,6])
C0023317 (UMLS CUI [1,7])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938873 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229090 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LNUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
CL Item
Absent (NUC-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (NUC-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (NUC-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (NUC-D)
C0332241 (UMLS CUI [1,1])
LNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: LEFT EYE - RESCALED (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C2938873 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0681889 (UMLS CUI [1,4])
C0229090 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: LEFT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C2938873 (UMLS CUI [1,3])
C0449820 (UMLS CUI [1,4])
C0229090 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229090 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
LPSC
Code List
FINAL PSC OPACITY PHENOTYPE - LEFT EYE (ALL PARTICIPANTS)
CL Item
Absent (PSC-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (PSC-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (PSC-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (PSC-D)
C0332241 (UMLS CUI [1,1])
LPSCSCORE
Item
FINAL PREDICTED PSC OPACITY: PERCENTAGE CENTRAL 5 MM - LEFT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C4228349 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0205099 (UMLS CUI [1,5])
C0229090 (UMLS CUI [1,6])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938873 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0027361 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
NUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
CL Item
Absent (0)
C0332197 (UMLS CUI [1,1])
CL Item
Present (1)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (2)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (3)
C0332241 (UMLS CUI [1,1])
Item
FINAL PSC OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0027361 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
PSC
Code List
FINAL PSC OPACITY PHENOTYPE - PERSON (ALL PARTICIPANTS)
CL Item
Absent (0)
C0332197 (UMLS CUI [1,1])
CL Item
Present (1)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (2)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (3)
C0332241 (UMLS CUI [1,1])
RPSCBASE
Item
BASELINE PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0205099 (UMLS CUI [1,4])
C0229089 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229089 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RCOR
Code List
FINAL CORTICAL OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
CL Item
Absent (COR-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (COR-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (COR-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (COR-D)
C0332241 (UMLS CUI [1,1])
RCORBASE
Item
BASELINE CORTICAL OPACITY PERCENTAGE FULL VISIBLE LENS - RIGHT EYE (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C2938874 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0205379 (UMLS CUI [1,4])
C0023317 (UMLS CUI [1,5])
C0229089 (UMLS CUI [1,6])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RCORSCORE
Item
FINAL PREDICTED CORTICAL OPACITY PERCENTAGE: FULL VISIBLE LENS - RIGHT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C2938874 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0205379 (UMLS CUI [1,5])
C0023317 (UMLS CUI [1,6])
C0229089 (UMLS CUI [1,7])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C2938873 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229089 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RNUC
Code List
FINAL NUCLEAR OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
CL Item
Absent (NUC-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (NUC-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (NUC-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (NUC-D)
C0332241 (UMLS CUI [1,1])
RNUCBASE
Item
BASELINE NUCLEAR OPACITY SCORE: RIGHT EYE - RESCALED (ALL PARTICIPANTS)
float
C1442488 (UMLS CUI [1,1])
C2938873 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0681889 (UMLS CUI [1,4])
C0229089 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RNUCSCORE
Item
FINAL PREDICTED NUCLEAR OPACITY SCORE: RIGHT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C2938873 (UMLS CUI [1,3])
C0449820 (UMLS CUI [1,4])
C0229089 (UMLS CUI [1,5])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Item
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
text
C3853528 (UMLS CUI [1,1])
C4228349 (UMLS CUI [1,2])
C0031437 (UMLS CUI [1,3])
C0229089 (UMLS CUI [1,4])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
RPSC
Code List
FINAL PSC OPACITY PHENOTYPE - RIGHT EYE (ALL PARTICIPANTS)
CL Item
Absent (PSC-A)
C0332197 (UMLS CUI [1,1])
CL Item
Present (PSC-B)
C0150312 (UMLS CUI [1,1])
CL Item
Cataract Surgery (PSC-C)
C2939459 (UMLS CUI [1,1])
CL Item
Questionable (PSC-D)
C0332241 (UMLS CUI [1,1])
RPSCSCORE
Item
FINAL PREDICTED PSC OPACITY PERCENTAGE: CENTRAL 5 MM - RIGHT EYE (ALL PARTICIPANTS)
float
C3853528 (UMLS CUI [1,1])
C0681842 (UMLS CUI [1,2])
C4228349 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0205099 (UMLS CUI [1,5])
C0229089 (UMLS CUI [1,6])
C0681850 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Tillbaka till toppen